Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, Steinbeis F, Haffke M, Rudolf G, Heidecker B, Bobbert T, Spranger J, Volk HD, Skurk C, Konietschke F, Paul F, Behrends U, Bellmann-Strobl J, Scheibenbogen C. Kedor C, et al. Among authors: konietschke f. Nat Commun. 2022 Oct 12;13(1):6009. doi: 10.1038/s41467-022-33784-x. Nat Commun. 2022. PMID: 36224219 Free PMC article. No abstract available.
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, Hanitsch L, Wittke K, Bauer S, Konietschke F, Paul F, Bellmann-Strobl J, Kedor C, Scheibenbogen C, Sotzny F. Haffke M, et al. Among authors: konietschke f. J Transl Med. 2022 Mar 22;20(1):138. doi: 10.1186/s12967-022-03346-2. J Transl Med. 2022. PMID: 35317812 Free PMC article.
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, Steinbeis F, Haffke M, Rudolf G, Heidecker B, Bobbert T, Spranger J, Volk HD, Skurk C, Konietschke F, Paul F, Behrends U, Bellmann-Strobl J, Scheibenbogen C. Kedor C, et al. Among authors: konietschke f. Nat Commun. 2022 Aug 30;13(1):5104. doi: 10.1038/s41467-022-32507-6. Nat Commun. 2022. PMID: 36042189 Free PMC article.
Outcomes of Endurant II Stent Graft According to Anatomic Severity Grade Score.
Omran S, Müller V, Schawe L, Bürger M, Kapahnke S, Bruder L, Haidar H, Konietschke F, Greiner A. Omran S, et al. Among authors: konietschke f. J Endovasc Ther. 2023 Aug;30(4):600-608. doi: 10.1177/15266028221090433. Epub 2022 Apr 25. J Endovasc Ther. 2023. PMID: 35466775 Free PMC article.
Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study.
Leyvraz S, Konietschke F, Peuker C, Schütte M, Kessler T, Ochsenreither S, Ditzhaus M, Sprünken ED, Dörpholz G, Lamping M, Rieke DT, Klinghammer K, Burock S, Ulrich C, Poch G, Schäfer R, Klauschen F, Joussen A, Yaspo ML, Keilholz U. Leyvraz S, et al. Among authors: konietschke f. Eur J Cancer. 2022 Jul;169:146-155. doi: 10.1016/j.ejca.2022.04.004. Epub 2022 May 12. Eur J Cancer. 2022. PMID: 35569281
MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed.
Beetz NL, Dräger F, Hamm CA, Shnayien S, Rudolph MM, Froböse K, Elezkurtaj S, Haas M, Asbach P, Hamm B, Mahjoub S, Konietschke F, Wechsung M, Balzer F, Cash H, Hofbauer S, Penzkofer T. Beetz NL, et al. Among authors: konietschke f. Prostate Cancer Prostatic Dis. 2023 Sep;26(3):543-551. doi: 10.1038/s41391-022-00599-2. Epub 2022 Oct 8. Prostate Cancer Prostatic Dis. 2023. PMID: 36209237 Free PMC article.
Sample size planning for multiple contrast tests.
Pöhlmann A, Konietschke F. Pöhlmann A, et al. Among authors: konietschke f. Biom J. 2023 Dec;65(8):e2200081. doi: 10.1002/bimj.202200081. Epub 2023 Sep 4. Biom J. 2023. PMID: 37667451
85 results